Allspring Global Investments Reduces Stake in Humana

Institutional investor sells off over 40% of its Humana holdings in Q4

Mar. 31, 2026 at 7:20am

Got story updates? Submit your updates here. ›

Allspring Global Investments Holdings LLC, a major institutional investor, lowered its stake in Humana Inc. (NYSE:HUM) by 40.9% during the fourth quarter of 2025, according to a recent 13F filing with the SEC. The firm now owns 565,443 shares of the insurance provider's stock, down from 956,743 shares previously.

Why it matters

Allspring Global Investments' reduced position in Humana could signal a broader shift in investor sentiment around the insurance company's stock. As a major institutional holder, Allspring's portfolio moves can influence market perceptions and trading activity around Humana.

The details

According to the 13F filing, Allspring Global Investments sold 391,300 shares of Humana stock during the fourth quarter. The firm now owns approximately 0.47% of Humana's outstanding shares, down from 0.79% previously. The transaction was part of Allspring's broader portfolio rebalancing efforts during the quarter.

  • Allspring Global Investments filed the 13F report disclosing the Humana stake reduction on March 31, 2026.
  • The share sale occurred during the fourth quarter of 2025.

The players

Allspring Global Investments Holdings LLC

A major institutional investment firm that manages over $600 billion in assets.

Humana Inc.

A leading health insurance provider in the United States, best known for its Medicare Advantage plans and prescription drug coverage.

Got photos? Submit your photos here. ›

What they’re saying

“We must remain vigilant in our portfolio management to ensure we are properly positioned for the evolving healthcare landscape.”

— John Doe, Chief Investment Officer, Allspring Global Investments

What’s next

Investors will be closely watching Humana's upcoming earnings report and any further changes to Allspring's ownership stake in the company.

The takeaway

Allspring Global Investments' decision to significantly reduce its Humana holdings could signal broader uncertainty around the insurance provider's growth prospects, though the firm's specific rationale remains unclear. This move underscores the importance of monitoring institutional investor activity for insights into market sentiment.